REAPPRAISAL OF HYPOTHESIS-TESTING FOR METHOD VALIDATION - DETECTION OF SYSTEMATIC-ERROR BY COMPARING THE MEANS OF 2 METHODS OR OF 2 LABORATORIES

被引:134
作者
HARTMANN, C [1 ]
SMEYERSVERBEKE, J [1 ]
PENNINCKX, W [1 ]
VANDERHEYDEN, Y [1 ]
VANKEERBERGHEN, P [1 ]
MASSART, DL [1 ]
机构
[1] FREE UNIV BRUSSELS,INST PHARMACEUT,B-1090 BRUSSELS,BELGIUM
关键词
D O I
10.1021/ac00120a011
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The usual way of testing the equivalence of two measurement procedures is analyzed, and possible alternatives are discussed. It is concluded that for method validation purposes, defining an interval of acceptable values and applying interval hypothesis tests is to be preferred over the usually applied point hypothesis tests. Statistically testing against acceptance limits has the advantage that the beta-error of the usual null hypothesis (there is no bias) can be limited. It is shown that significance testing at a fixed beta-error requires, however, reversal of the usual null and alternative hypotheses. Equations are presented for the case in which the acceptable bias is expressed as a ratio of the reference mean. Moreover, the principle of randomization tests is explained, and their possible advantages over the ordinary test statistics in method validation are discussed.
引用
收藏
页码:4491 / 4499
页数:9
相关论文
共 11 条
  • [1] BOX GEP, 1978, STATISTICS EXPT
  • [2] Edgington E. S., 1987, RANDOMIZATION TESTS
  • [3] AN ANALYSIS OF THE WASHINGTON CONFERENCE REPORT ON BIOANALYTICAL METHOD VALIDATION
    HARTMANN, C
    MASSART, DL
    MCDOWALL, RD
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1994, 12 (11) : 1337 - 1343
  • [4] KELLY PC, 1990, J ASSOC OFF ANA CHEM, V73, P58
  • [5] AN EXACT CONFIDENCE-INTERVAL FROM UNTRANSFORMED DATA FOR THE RATIO OF 2 FORMULATION MEANS
    LOCKE, CS
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1984, 12 (06): : 649 - 655
  • [6] A COMPARISON OF THE 2 ONE-SIDED TESTS PROCEDURE AND THE POWER APPROACH FOR ASSESSING THE EQUIVALENCE OF AVERAGE BIOAVAILABILITY
    SCHUIRMANN, DJ
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1987, 15 (06): : 657 - 680
  • [7] ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE AND PHARMACOKINETIC STUDIES
    SHAH, VP
    MIDHA, KK
    DIGHE, S
    MCGILVERAY, IJ
    SKELLY, JP
    YACOBI, A
    LAYLOFF, T
    VISWANATHAN, CT
    COOK, CE
    MCDOWALL, RD
    PITTMAN, KA
    SPECTOR, S
    ALBERT, KS
    BOLTON, S
    COOK, CE
    DIGHE, S
    DOBRINSKA, M
    DOUB, W
    EICHELBAUM, M
    FINDLAY, JWA
    GALLICANO, K
    GARLAND, W
    HARDY, DJ
    HULSE, JD
    KARNES, HT
    MCDOWALL, RD
    LANGE, R
    LAYLOFF, T
    MASON, WD
    MCKAY, G
    MCGILVERAY, IJ
    MIDHA, KK
    ORMSBY, E
    OVERPECK, J
    PITTMAN, KA
    PLATTENBERG, HD
    SHAH, VP
    SHIU, G
    SITAR, D
    SKELLY, JP
    SORGEL, F
    SPECTOR, S
    STEWART, JT
    VISWANATHAN, CT
    YACOBI, A
    YUH, L
    [J]. PHARMACEUTICAL RESEARCH, 1992, 9 (04) : 588 - 592
  • [8] Steinijans V. W., 1993, Clinical Research and Regulatory Affairs, V10, P203, DOI 10.3109/10601339309079568
  • [9] STEINIJANS VW, 1990, INT J CLIN PHARM TH, V30, pS45
  • [10] A NEW APPROACH FOR DEALING WITH THE STABILITY OF DRUGS IN BIOLOGICAL-FLUIDS
    TIMM, U
    WALL, M
    DELL, D
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (09) : 972 - 977